The Institute of Medicine has called for a national drug-tracking system following an FDA warning on counterfeit Avastin. Such a system might utilize barcodes or electronic tags to confirm the authenticity of a medication and the ingredients used during its production, an expert said. FDA Commissioner Dr. Margaret Hamburg lauded the report.
IOM: Tracking system needed to curb sales of fake drugs
SmartBrief Job Listings for Health Care